Table 2 Multivatiate analysis for disease-free and overall survival in our included studies
From: Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis
Study (Reference) | Multivariate analysis | DFS | OS | ||||
|---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | ||
Shirakawal18 | Yes | NA | NA | NA | 1.84 | 1.04-3.25 | 0.034 |
Yorita19 | Yes | 3.6 | 1.8-7.1 | 0.0003 | 1.9 | 0.7-5.1 | 0.176 |
Su20 | Yes | NA | NA | NA | 1.905 | 1.063-3.415 | 0.030 |
Yu21 | NA | NA | NA | NA | NA | NA | NA |
Wang23 | NA | NA | NA | NA | NA | NA | NA |
Chen24 | Yes | 2.27 | 1.14-4.51 | 0.02 | NA | NA | NA |
Fu25 | Yes | 2.14 | 1.39-3.29 | 0.001 | 2.29 | 1.35-3.89 | 0.002 |
Liang26 | NA | NA | NA | NA | NA | NA | NA |